A process for preparing the beta-(3,4-dihydroxyphenyl)-alpha-borneol hydroxypropionate used for preventing and treating cardiovascular and cerebrovascular diseases features the catalytic reaction between beta-(3,4- dihydroxyphenyl)-alpha-hydroxypropionic acid and borneol in the solvent under existence of Liews acid at 65-150 deg.C for 8-12 hr.